Pneumocystis jiroveci pneumonia in patients with non-Hodgkin’s lymphoma after Rituximab-containing regimen: two cases of report and literature review

Rituximab, a monoclonal antibody against CD20+ antigen specific B cell, has been increasingly used in the treatment of non-Hodgkin’s lymphoma and some other autoimmune diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. It is noted that Rituximab could enhanced the efficac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jiang, Xu-Qin, Fang, Lei, Mei, Xiao-Dong, Wang, Xiao-Jing, Bao, Ming-Hong
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755685/
https://ncbi.nlm.nih.gov/pubmed/23991330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.08.35
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars